Event's Program
Opening: Organizing Committee
08.30 -08.40
Session 1: Immune Responses Against Tumors and Their Regulation Within the Tumor Microenvironment (part I)
Chairs: C.N. Baxevanis, M Goulielmaki
Decoding immune escape: the basis for advancing (immuno) therapies
09.00 - 09.20
Prof. Dr., Martin-Luther-Universität Halle-Wittenberg Institut für Medizinische Immunologie
Discussion
09.20 - 09.40
Coffee Break
09.40 - 10.00
Session 2: Immune Responses Against Tumors and Their Regulation Within the Tumor Microenvironment (part II)
Chairs: B. Seliger – I. Nikas
Pre-existing Antitumor Immunity in NSCLC
10.00 - 10.20
Postdoctoral Researcher at Laboratory of Oncology, Medical School of Thessaly, Larisa
Non-alcoholic steatohepatitis to hepatocellular carcinoma: the role of inflammation
10.20 - 10.40
Associate Professor of Experimental and Clinical Physiology Department of Physiology, School of Medicine, National and Kapodistrian University of Athens
Modulating fibroblast populations in pancreatic cancer - implications on the immune microenvironment
10.40 - 11.00
M.D, Ph.D., Assistant Professor and Consultant Oncologist Wallenberg Molecular Medicine Fellow
Discussion
11.00 - 11.20
Session 3: The Role of Microbiota in Immune Regulation
Chairs: S. Karagiannis – C. Gouttefangeas
Decoding the Immune Microenvironment: Crossroads of Infection and Cancer
11.20 - 11.40
PhD, Professor in Cell and Molecular Biology at Umeå University
Microbiota-gut-brain axis in glioblastoma?
11.40 -12.00
Associate Professor Université de Bordeaux
Discussion
12.00 - 12.20
Oral presentations
12.20 - 13.40
Chairs: J. Wischhusen, A. Xagara
Light Lunch
13.40 - 14.40
Session 4: Innovative Therapeutic Approaches Against Cancer (Part I)
Charis T. Frisan – L. Conti
Challenges in the Development of an Academic CAR-T Cell Program in Emerging Countries
14.40 - 15.00
Lessons from pregnancy for immunomodulation in cancer and autoimmunity
15.00 - 15.20
Professor of Experimental Tumor Immunology University of Würzburg School of Medicine Department of Gynecology and Obstetrics
T cell therapy in melanoma
15.20 - 15.40
Senior Scientist; PhD, Group leader & Head of Immunomonitoring
Discussion
15.40 - 16.00
Coffee Break
16.00 - 16.20
Educational lectures
16.20 - 17.50
Educational lecture - Identification of T cell target antigens in small cell lung cancer
16.20 - 16.50
Group leader at the Institute for Cell Biology, Department of Immunology, Tübingen.
Educational lecture - Systemic immune response in pancreatic cancer - potential role for immunotherapy
16.50 - 17.20
Assistant Professor, Docent
Educational lecture - Toll-like Receptor 2-Targeted Therapies Enhance Chemotherapy and Immunotherapy Efficacy in Breast Cancer
17.20 - 17.50
Associate Professor in Immunology and General Pathology, Department of Molecular Biotechnology and Health Sciences, University of Turin, c/o Molecular Biotechnology Center “Guido Tarone”, OncoImmunology group, Torino
Discussion
17.50 - 18.20
Coffee Break
18.20 - 18.30
Session: IO in GU
18.30 - 19.10
Chairs: Κ. Dimitropoulos (GR), F. Koinis (GR)
Immunotherapy in urothelial carcinomas
18.30 - 18.50
MD, PhD, Assistant Professor of Medical Oncology, School of Medicine, University of Thessaly, Dpt. of Medical Oncology, University General Hospital of Larissa
Advances in immunotherapy in renal cell carcinoma
18.50 - 19.10
Medical Oncologist
Discussion
19.10 - 19.30
Interactive session with the Speakers from Day 1
19.30 - 12.00
S. Karagiannis – J. Wischhusen – I.Pateras – T. Frisan
Session 5: Diagnostic and Prognostic Markers in Oncology (part I)
Chairs: G. Kallergi – I. Pateras
Decoding the Tumor Microenvironment: Analysis of Multiple Biomarkers in Human Tissues
08.40 - 09.00
Assistant Professor, University of Cyprus
CTCs pancreas - Circulating Tumor Cells (CTCs) and immune checkpoints molecules; Clinical relevance and perspectives
09.00 - 09.20
Associate Professor of Biochemistry, University of Patras
Emerging Immune Biomarkers in Prevalent Solid Tumors
09.20 - 09.40
Associate Professor, 2nd Department of Pathology, "Attikon" University Hospital, Medical School, National and Kapodistrian University of Athens, Greece.
Advancing cancer diagnosis and prognosis with spatial transcriptomics and AI
9.40 - 10.00
Assistant Professor, University of Thessaly, Larissa
Discussion
10.00 - 10.20
Coffee Break
10.20 - 10.50
Session 6: Advanced Therapeutic Modalities Targeting Cancer (part II)
Chairs G. Kallergi – I. Pateras
Allotypic variation in antigen presentation regulates the immunopeptidome of cancer cells
10.50 - 11.10
Design of monoclonal antibody therapies for solid tumours through the study of patient immune responses
11.10 - 11.30
Professor of Translational Cancer Immunology and Immunotherapy, St. John’s Institute of Dermatology, School of Basic & Medical Biosciences, King’s College London
Discussion
11.30 - 11.50
Oral presentations
11.50 - 12.30
Chair: O. Martin – I. Nikas
Keynote lecture - Immunotherapy in breast cancer past present future – beyond triple negative?
12.30 - 13.00
Chairs: V. Georgoulias – T. Frisan
Professor of Oncology
Light Lunch
13.00 - 14.00
Session 7: Diagnostic and Prognostic Markers in Oncology (part II)
Chairs: E. Stratikos – S. Karagiannis
The role of T cells as biomarkers in cancer
14.00 - 14.20
Postdoctoral Researcher at Cancer Immunology and Immunotherapy Center, Athens
Dissecting the tumor microenvironment in early breast cancer: clinical implications and novel insights
14.20 - 14.40
Targeting TNF Receptors for Tumor Therapy
14.40 - 15.00
Professor, Interdisciplinary Center for Clinical Research Laboratory for Experimental Stem Cell Transplantation at the Department of Medicine II, Würzburg University Medical School
The Role of Epigenetic Modulation in Tumorigenesis?
15.00 - 15.20
PhD, Investigator - Professor Level
Discussion
15.20 - 15.40
Session 8: Melanoma Immunotherapy: Then, Now, and Beyond
Chairs: V. Papadopoulos, E. Zafeiriou
10 years of Immunotherapy in Melanoma
15.40 - 16.10
Director of Oncology Department at Athens Medical Group
Sponsored lecture - Melanoma
16.10 - 16.40
Director, Melanoma Portfolio / Product Design & Delivery, Worldwide Medical | Oncology, Bristol Myers Squibb
Discussion
16.40 - 17.00
Coffee break
17.00 - 17.15
Session 9: Non-small cell lung cancer Immunotherapy: Then, Now, and Beyond Chairs:
Chairs: A. Kotsakis, K. Tsapakidis
Sponsored lecture - Reinforcing therapeutic options for patients with NSCLC and PD-L1 positive expression without driver mutations.
17.15 - 17.45
MSc, PhD, Medical Oncologist, Director, 4th Oncology Department and Clinical Trials Unit Henry Dunant Hospital Center, Athens
Sponsored lecture - Shaping the Future of resectable NSCLC: Exploring the latest Therapeutic Strategies
17.45 - 18.15
Medical Oncologist, 1st Medical Oncology Dpt., Theagenio Cancer Hospital of Thessaloniki
Sponsored lecture - Bridging the gap with dual immunotherapy in patients with metastatic NSCLC and low PD-L1 expression.
18.15 - 18.45
MD, PhD, Assistant Professor of Medical Oncology, First Department of Internal Medicine, Laikon General Hospital, School of Medicine, National and Kapodistrian University of Athens
Discussion
18.45 - 19.00
Coffee Break
19.00 - 19.20
Educational lectures
19.20 - 20.00
Chair: V. Georgoulias, E. Saloustros
Educational lecture - Novel therapeutic approaches in gynecological cancer
19.20 - 19.40
Medical Oncologist, Assistant Professor,Alexandra Hospital, Medical School, National and Kapodistrian University of Athens
Educational lecture - MTAP deleted cancers
19.40 - 20.00
Assistant Professor, Rochester, MN, Oncology
Educational lectures
20.00 - 20.30
Chair: A. Kotsakis, V. Georgoulias
Educational lecture - Pathology in the era of precision oncology
20.00 - 20.30
Pathologist, Professor, Attikon Hospital, Athens
Interactive session with the Speakers from Day 2
20.30 - 21.30
Session 11: Advances in immunotherapy in GI as Monotherapy and in Combination with Other Treatment Modalities
Chairs: G. Samaras, F. Koinis
IO in cholangiocarcinoma
08.40 - 09.00
MD, PhD, Medical oncologist, Metropolitan Hospital
IO in gastric and gastroesophageal carcinoma
09.00 - 09.20
MD, Medical Oncologist, HYGEIA Hospital
IO in colorectal carcinoma
09.20 - 09.40
MD, Medical Oncologist, Saint Savvas Hospital
Discussion
09.40 - 10.00
Coffee break
10.00-10.20
Educational lectures:
10.20 - 11.20
Chairs: A. Kotsakis, V. Papadopoulos
Educational lecture - Sponsored lecture: Recent updates in resectable Locally Advanced Head and Neck cancer.
10.20 - 10.50
Medical Oncologist, Consultant of Medical Oncology, Day Care Unit, Papanikolaou General Hospital, Thessaloniki
Educational lecture - HLA-class-I expression loss in cancer and therapeutic restoration:the role of Radiotherapy and Autophagy
10.50 - 11.20
Professor of Radiation Oncology, Medical School, Democritus University of Thrace, Alexandroupolis
Abstracts Awards
11.20 - 11.30
Organizing Committee
Interactive session with the Speakers day 3
11.30 - 12.00
S.Karagiannis – J. Wischhusen – I.Pateras – T. Frisan
Concluding remarks
12.00 - 12.20